Alan Shuldiner, MD, Endocrinology, Baltimore, MD, University of Maryland Medical Center

AlanRShuldinerMD

Endocrinology Baltimore, MD

Diabetes, Lipid Metabolism

Professor of Medicine, University MD School of Medicine

Dr. Shuldiner is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shuldiner's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes and Metabolism, 1986 - 1990
  • New York Presbyterian Hospital -  Columbia Campus
    New York Presbyterian Hospital - Columbia CampusInternship, Internal Medicine, 1984 - 1985
  • Harvard Medical School
    Harvard Medical SchoolClass of 1984

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2005 - 2020
  • MD State Medical License
    MD State Medical License 1987 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Vitamin D Inhibits Human Platelet Aggregation: Implications for Hypercoagulable State in Diabetes 
    Baltimore, MD - 6/15/2014

Press Mentions

  • Whole Genome Sequencing Identifies High-Impact Variants in Well-Known Pharmacogenomic Genes
    Whole Genome Sequencing Identifies High-Impact Variants in Well-Known Pharmacogenomic GenesSeptember 14, 2018 17:45
  • Increasing Fiber Decreases Major Health Risks
    Increasing Fiber Decreases Major Health RisksNovember 20, 2017 10:18
  • Mutation Protects Swiss Amish in Indiana from Diabetes, Extends Life ... Maybe
    Mutation Protects Swiss Amish in Indiana from Diabetes, Extends Life ... MaybeNovember 18, 2017 10:45
  • Join now to see all

Grant Support

  • Secondary Prevention Of Subcortical Stroke Prevention Genetic SubstudyNational Institute Of Neurological Disorders And Stroke2011–2012
  • Research BaseNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Mid-Atlantic Nutrition Obesity Research CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Administrative CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Pharmacogenomics Of Anti-Platlet Intervention-2 (Papi-2) StudyNational Heart, Lung, And Blood Institute2010–2011
  • The Thrifty Microbiome: The Role Of The Gut Microbiota In Obesity In The AmishNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
  • Clinical Nutrition Research Unit Of MarylandNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
  • Pharmacogenomics Of Anti-Platelet Agents For CVD PreventionNational Institute Of General Medical Sciences2007–2009
  • Genetics CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Pharmacogenomics Of CVD Risk ReductionNational Institute Of General Medical Sciences2005–2009
  • Clinical Research Career Development (RMI)National Center For Research Resources2005–2009
  • Genetics Of Diabetes In The AmishNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2009
  • Genome-Wide Search For CVD Gene-Environment InteractionsNational Heart, Lung, And Blood Institute2002–2008
  • Pharmacogenomics Of Anti-Platelet Agents For CVD PreventNational Institute Of General Medical Sciences2005–2006
  • Core--Genetics, Genomics, And Genetic EpidemiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Pharmacogenetics Of PRO 12ala Ppar-Gamma-2National Center For Research Resources2005–2006
  • Genome Wide Research For CVD Gene Environment InteractionNational Center For Research Resources2005
  • Genetics Of Diabetes And ObesityNational Center For Research Resources2004–2005
  • Longevity Genes In Founder PopulationsNational Institute On Aging2001–2005
  • Pharmacogenetics Of PPAR - GammaNational Center For Research Resources2004
  • Genetics Of Longevity In The AmishNational Center For Research Resources2004
  • Amish Family Osteoporosis StudyNational Center For Research Resources2004
  • Genetic And Clinical Manifestations Of DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • Genetics Of Osteoporosis In The AmishNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2004
  • MALDI-TOF MS For High Throughput SNP AnalysisNational Center For Research Resources2002
  • Pharmacogenetics Of Pro12ala PPAR Gamma 2 In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Genetics Of Type II Diabetes Mellitus And ObesityNational Center For Research Resources2000
  • B3 Receptor Gene Mutation In Diabetes Prone MinoritiesNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1998
  • B3 Receptor Gene Mutation In Diabetes Prone MinoritiesNational Institute Of Diabetes And Digestive And Kidney Diseases1996

Hospital Affiliations